NCT06037785

Brief Summary

This study, "Biobehavioral Intervention to Reduce PTSD Symptoms After an ICD Shock," addresses a critical need in cardiology care by describing the feasibility and acceptability of a timely, highly promising, electronically-delivered intervention for patients who have recently received an ICD delivered shock. The study intervention and outcomes are designed to reduce anxiety, enhance return to activities of daily living (ADLs), and prevent the development of severe distress and post-traumatic stress disorder (PTSD), and ultimately promote quality of life. The study is a two-arm, embedded mixed methods, randomized trial (N=60, 30/group). The purpose is to determine feasibility and potential effects of a self-management intervention (SPSM) plus usual care (UC) compared to UC alone, delivered during the critical 1 month period after an ICD shock when distress is high. The intervention will be delivered over 1 month following an ICD shock; a 6-month follow-up will be used to assess the sustainability of intervention effects and determine if the incidence of PTSD is reduced. SPSM includes: 1) training in heart rate (HR) self-monitoring; and 2) individualized learning through 4 self-paced, web-based modules. The study interventions are delivered at a crucial time, closely after an ICD shock when stress is high, but PTSD has not yet developed. The specific aims are to: 1) examine the effects of the SPSM intervention plus UC vs. UC alone on the primary outcome of ICD shock anxiety at 1 and 6 months post-shock event, 2) describe the impact of SPSM plus UC compared to UC alone on the secondary outcomes of total daily physical activity, depression, PTSD symptoms, QOL, salivary cortisol levels, and self-efficacy and outcome expectations at 1 and 6 months post-shock event, and 3) assess feasibility, acceptability, and safety of the SPSM intervention, SDOH will be used to describe differential responses to the SPSM intervention. This study fills a significant gap in the care of patients with an ICD, through the systematic testing of a brief, novel and cost-effective intervention that provides the knowledge and skills to improve quality of life. Study findings will be used to design future larger RCTs to test intervention effectiveness for more diverse samples and settings.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Oct 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Oct 2024Jul 2026

First Submitted

Initial submission to the registry

September 1, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

September 14, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Last Updated

September 24, 2025

Status Verified

September 1, 2025

Enrollment Period

1.8 years

First QC Date

September 1, 2023

Last Update Submit

September 22, 2025

Conditions

Keywords

implantable cardioverter defibrillatorptsdstress management

Outcome Measures

Primary Outcomes (1)

  • ICD Shock anxiety

    Florida Shock Anxiety Scale: range 1-50, higher is higher anxiety.

    Baseline, 1, 6 months

Secondary Outcomes (8)

  • Total daily physical activity(steps/day)

    Baseline, 1, 6 months

  • Depression

    Baseline, 1, 6 months

  • PTSD Symptoms

    Baseline, 1, 6 months

  • Quality of Life-Physical and Mental

    Baseline, 1, 6 months

  • Self-Efficacy Expectations

    Baseline, 1, 6 months

  • +3 more secondary outcomes

Other Outcomes (3)

  • Feasibility of implementing the intervention (composite outcome)

    6 months

  • Safety (composite outcome) of the intervention

    2 years of the trial

  • Acceptability of the intervention (composite outcome)

    6 months

Study Arms (2)

SPSM intervention

EXPERIMENTAL

Heart rate self monitoring Online shock management modules

Behavioral: Self-Paced Self-Management (SPSM)

usual care

NO INTERVENTION

standard observation and post-ICD shock care at each clinic that includes ICD interrogations monitored in-person or via home monitor

Interventions

(SPSM) consists of two components: 1) HR Self-monitoring, and 2) online Shock Management modules (N=4) with weekly telephone coaching, completed over 1 month.

SPSM intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ICD implant for primary or secondary prevention of sudden cardiac arrest (SCA),
  • receipt of at least 1 ICD shock, appropriate or inappropriate, one week prior to enrollment;
  • able to read, speak and write English;
  • access to online resources and telephone for study duration.

You may not qualify if:

  • current diagnosis of PTSD, schizophrenia or bipolar disorder;
  • Short BLESSED score \>6 indicating cognitive dysfunction \[73\];
  • age \<18 years;
  • AUDIT-C score ≥4 for alcohol use;
  • regular non-medical use of illicit drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Washington

Seattle, Washington, 98195, United States

RECRUITING

MeSH Terms

Conditions

Fractures, StressStress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesStress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Cynthia M Dougherty, ARNP, PhD

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cynthia M Dougherty, ARNP, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, School of Nursing

Study Record Dates

First Submitted

September 1, 2023

First Posted

September 14, 2023

Study Start

October 1, 2024

Primary Completion (Estimated)

July 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

September 24, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

To support efforts by other researchers in replicating this study, and clinicians and healthcare systems to implement the interventions, we will 1) share the detailed study protocol, patient provider intervention materials, measures, and tools; 2) share a de-identified dataset.

Shared Documents
STUDY PROTOCOL
Time Frame
1 year after trial completion, available for up to 5 years after trial completion
Access Criteria
Contact PI
More information

Locations